Eric Koskins is an accomplished consultant and healthcare expert with a diverse academic background in healthcare economics, public health/ epidemiology, and life sciences. Currently at McKinsey & Company, he focuses on providing detailed solutions to various pharmaceutical and private equity clients. Eric is a dedicated contributor to the McKinsey Cancer Center, assisting oncology clients globally with a variety of services, such as pharmaceutical R&D support, market access and reimbursement, cell therapy, healthcare economic evaluation, launch strategy, and public health advice.

Eric holds a Master of Science, with Distinction (First Class Honours), in Health Economics from The London School of Economics and Political Science (LSE) alongside a Master of Public Health in Epidemiology from Queen's University. He earned his Bachelor's Degree in Life Sciences, with a minor in Economics, also from Queen's University. With his profound knowledge and expertise, Eric has become a valuable asset to the McKinsey team.